Forbes August 17, 2023
Alison Durkee

Topline

A federal appeals court ruled Wednesday to reinstate restrictions on the abortion drug mifepristone, such as no longer making it available via telehealth, but an April ruling from the Supreme Court means the medication’s availability is still the same as it was before for the foreseeable future, until the high court rules in the case.

Key Facts

What To Watch For

The Supreme Court’s ruling leaves the existing protocols for mifepristone in place until the high court rules in the case, if it decides to take it up, and says the lower court’s ruling will go immediately into effect if justices decide not to hear the case. The Justice Department said Wednesday it “will be seeking Supreme Court review”...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Mastery of language could predict longevity
Most Americans Don’t Know About Medical Aid in Dying Options
Emirates improves in-flight digital medical care
Reimagining Mental Healthcare: We Need A New Road, Not A Bigger Truck
14 tips to guide patients through a cancer diagnosis

Share This Article